FIGURE 1.

Translational pharmacomicrobiomics. With careful study design, pharmacomicrobiomics datasets will be invaluable in uncovering drug response heterogeneity that may or may not be useful in clinical prediction. Through biopsy or stool sample collection, the microbiome can be surveyed through the metagenome (DNA), metatranscriptome (RNA), metametabolome (metabolites), metaproteome (proteins), and an ever‐increasing amount of biological data. Typical analyses include profiling communities for their species and functional potential, and creating networks to uncover relationships hidden in the expansive data.